Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,912 | -455 | -112 | -110 | -22 |
| Depreciation Amortization | 1 | 4 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | 201 | 23 | -5 | N/A | 35 |
| Other Working Capital | 412 | 17 | -38 | 50 | 35 |
| Other Operating Activity | -23 | -23 | 5 | 10 | -35 |
| Operating Cash Flow | $-1,322 | $-435 | $-150 | $-50 | $13 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | N/A | N/A | 0 | N/A |
| Investing Cash Flow | $-28 | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -24 | -24 | -13 | N/A | N/A |
| Common Stock Issued | 15,405 | N/A | N/A | N/A | 1 |
| Other Financing Activity | -1,883 | 496 | 398 | 470 | -11 |
| Financing Cash Flow | $13,498 | $472 | $385 | $470 | $-10 |
| Beginning Cash Position | 424 | 424 | 424 | 2 | N/A |
| End Cash Position | 12,573 | 462 | 660 | 420 | 3 |
| Net Cash Flow | $12,148 | $37 | $235 | $420 | $3 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,322 | -435 | -150 | -50 | 13 |
| Capital Expenditure | -28 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,350 | -435 | -150 | -50 | 13 |